DEA Proposes Adding 5 More Psychedelics to Schedule 1 Controlled Substances
Agency argues these five tryptamines “have no known medical use,” setting up a showdown with the emerging psychedelics industry.
Agency argues these five tryptamines “have no known medical use,” setting up a showdown with the emerging psychedelics industry.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.